Found: 11
Select item for more details and to access through your institution.
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells.
- Published in:
- International Journal of Cancer, 2003, v. 107, n. 3, p. 478
- By:
- Publication type:
- Article
Chemotherapy options in castration-resistant prostate cancer.
- Published in:
- Indian Journal of Urology, 2016, v. 32, n. 4, p. 262, doi. 10.4103/0970-1591.191239
- By:
- Publication type:
- Article
Prostate Cancer Immunotherapy: Promising Beginnings.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 3, p. 346
- By:
- Publication type:
- Article
Progressive Multifocal Leukoencephalopathy in a HIV-Negative Patient with Small Lymphocytic Leukemia following Treatment with Rituximab.
- Published in:
- Case Reports in Oncology, 2011, v. 4, n. 1, p. 136, doi. 10.1159/000326851
- By:
- Publication type:
- Article
Invasive Bladder Cancer Update--Anything New?
- Published in:
- AUANews, 2007, v. 12, n. 1, p. 8
- By:
- Publication type:
- Article
A Phase 1/2, open label dose-escalation and expansion trial of NKT2152, an orally administered HIF2α inhibitor, to investigate safety, PK, PD and clinical activity in patients with advanced ccRCC.
- Published in:
- Oncologist, 2023, v. 28, p. S12, doi. 10.1093/oncolo/oyad216.019
- By:
- Publication type:
- Article
Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.
- Published in:
- Oncologist, 2022, v. 27, n. 6, p. 432, doi. 10.1093/oncolo/oyab075
- By:
- Publication type:
- Article
A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 12, p. 1533, doi. 10.1007/s00262-016-1910-x
- By:
- Publication type:
- Article
Targeted therapies for renal cell carcinoma.
- Published in:
- Targeted Oncology, 2007, v. 2, n. 1, p. 7, doi. 10.1007/s11523-006-0041-2
- By:
- Publication type:
- Article